| __timestamp | Amicus Therapeutics, Inc. | Soleno Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 47624000 | 2242216 |
| Thursday, January 1, 2015 | 76943000 | 4536244 |
| Friday, January 1, 2016 | 104793000 | 5184803 |
| Sunday, January 1, 2017 | 149310000 | 3068742 |
| Monday, January 1, 2018 | 270902000 | 7178000 |
| Tuesday, January 1, 2019 | 286378000 | 16267000 |
| Wednesday, January 1, 2020 | 308443000 | 23191000 |
| Friday, January 1, 2021 | 272049000 | 21453000 |
| Saturday, January 1, 2022 | 276677000 | 15265000 |
| Sunday, January 1, 2023 | 152381000 | 25189000 |
Data in motion
In the competitive world of biotechnology, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Amicus Therapeutics, Inc. has consistently outpaced Soleno Therapeutics, Inc. in R&D investment. From 2014 to 2023, Amicus increased its R&D spending by over 220%, peaking in 2020 with a staggering 308 million dollars. In contrast, Soleno's R&D expenses grew by approximately 1,000% during the same period, yet their highest annual spend was just 25 million dollars in 2023. This stark difference highlights Amicus's aggressive pursuit of innovation, while Soleno's growth, though impressive in percentage terms, remains modest in absolute figures. As the biotech industry continues to evolve, these spending patterns may offer insights into future breakthroughs and market leadership.
Research and Development Expenses Breakdown: Johnson & Johnson vs Amicus Therapeutics, Inc.
Research and Development Expenses Breakdown: Novartis AG vs Amicus Therapeutics, Inc.
Analyzing R&D Budgets: Teva Pharmaceutical Industries Limited vs Soleno Therapeutics, Inc.
Research and Development Investment: Summit Therapeutics Inc. vs Soleno Therapeutics, Inc.
Pharming Group N.V. vs Soleno Therapeutics, Inc.: Strategic Focus on R&D Spending
Research and Development Investment: Axsome Therapeutics, Inc. vs Amicus Therapeutics, Inc.
Amneal Pharmaceuticals, Inc. vs Soleno Therapeutics, Inc.: Strategic Focus on R&D Spending
Rhythm Pharmaceuticals, Inc. vs Amicus Therapeutics, Inc.: Strategic Focus on R&D Spending
Research and Development Investment: Amicus Therapeutics, Inc. vs Taro Pharmaceutical Industries Ltd.
Comparing Innovation Spending: Amicus Therapeutics, Inc. and Xencor, Inc.
Research and Development Expenses Breakdown: Soleno Therapeutics, Inc. vs Travere Therapeutics, Inc.
Soleno Therapeutics, Inc. vs BioCryst Pharmaceuticals, Inc.: Strategic Focus on R&D Spending